Solid lipid nanoparticles as attractive drug vehicles: Composition, properties and therapeutic strategies

Mater Sci Eng C Mater Biol Appl. 2016 Nov 1:68:982-994. doi: 10.1016/j.msec.2016.05.119. Epub 2016 May 28.

Abstract

This work briefly reviews up-to-date developments in solid lipid nanoparticles (SLNs) as effective nanocolloidal system for drug delivery. It summarizes SLNs in terms of their preparation, surface modification and properties. The application of SLNs as a carrier system enables to improve the therapeutic efficacy of drugs from various therapeutic groups. Present uses of SLNs include cancer therapy, dermatology, bacterial infections, brain targeting and eye disorders among others. The usage of SLNs provides enhanced pharmacokinetic properties and modulated release of drugs. SLN ubiquitous application results from their specific features such as possibility of surface modification, increased permeation through biological barriers, resistance to chemical degradation, possibility of co-delivery of various therapeutic agents or stimuli-responsiveness. This paper will be useful to the scientists working in the domain of SLN-based drug delivery systems.

Keywords: Drug delivery systems; Lipids; Nanocolloidal carriers; Pharmacokinetics; Solid lipid nanoparticles; Therapeutic agents.

Publication types

  • Review

MeSH terms

  • Bacterial Infections / drug therapy
  • Brain Diseases / drug therapy
  • Drug Carriers* / chemistry
  • Drug Carriers* / therapeutic use
  • Eye Diseases / drug therapy
  • Lipids* / chemistry
  • Lipids* / therapeutic use
  • Nanoparticles / chemistry*
  • Neoplasms / drug therapy
  • Skin Diseases / drug therapy

Substances

  • Drug Carriers
  • Lipids